Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Keating

Showing results (321-330 of 436) with videos related to

Pageof 44
Sort By:
Blood|February 15, 1992
Intensive chemotherapy with mitoxantrone and high-dose cytosine arabinoside followed by granulocyte-macrophage colony-stimulating factor in the treatment of patients with acute lymphocytic leukemiaH M Kantarjian, E H Estey, S O'Brien, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 1, 1996
Correlation between selected environmental exposures and karyotype in acute myelocytic leukemiaM M Crane, S S Strom, S Halabi, et al.
The American Journal of Medicine|December 1, 1992
Prognostic significance of elevated serum beta 2-microglobulin levels in adult acute lymphocytic leukemiaH M Kantarjian, T Smith, E Estey, et al.
Blood|September 1, 1981
Treatment of patients over 50 years of age with acute myelogenous leukemia with a combination of rubidazone and cytosine arabinoside, vincristine, and prednisone (ROAP)M J Keating, K B McCredie, R S Benjamin, et al.
Blood|August 1, 1994
2-Chlorodeoxyadenosine therapy in patients with T-cell lymphoproliferative disordersS O'Brien, R Kurzrock, M Duvic, et al.
Leukemia|March 1, 1988
Multiple agent chemotherapy (POACH) in previously treated and untreated patients with chronic lymphocytic leukemiaM J Keating, M Scouros, S Murphy, et al.
The Journal of Clinical Investigation|July 1, 1985
Pretreatment of cytokinetics in acute myelogenous leukemia. Age-related prognostic implicationsH M Kantarjian, B Barlogie, M J Keating, et al.
Leukemia|September 1, 1995
A 3-day schedule of fludarabine in previously treated chronic lymphocytic leukemiaL E Robertson, S O'Brien, H Kantarjian, et al.
American Journal of Clinical Pathology|March 1, 1994
Detection of subgroups of chronic B-cell leukemias by FMC7 monoclonal antibodyY O Huh, W C Pugh, H M Kantarjian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Fludarabine--present status and future developments in chronic lymphocytic leukemia and lymphomaM J Keating, P McLaughlin, W Plunkett, et al.
Pageof 44

Showing results (321-330 of 436) with videos related to

Sort By:
Pageof 44
Blood|February 15, 1992
Intensive chemotherapy with mitoxantrone and high-dose cytosine arabinoside followed by granulocyte-macrophage colony-stimulating factor in the treatment of patients with acute lymphocytic leukemiaH M Kantarjian, E H Estey, S O'Brien, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 1, 1996
Correlation between selected environmental exposures and karyotype in acute myelocytic leukemiaM M Crane, S S Strom, S Halabi, et al.
The American Journal of Medicine|December 1, 1992
Prognostic significance of elevated serum beta 2-microglobulin levels in adult acute lymphocytic leukemiaH M Kantarjian, T Smith, E Estey, et al.
Blood|September 1, 1981
Treatment of patients over 50 years of age with acute myelogenous leukemia with a combination of rubidazone and cytosine arabinoside, vincristine, and prednisone (ROAP)M J Keating, K B McCredie, R S Benjamin, et al.
Blood|August 1, 1994
2-Chlorodeoxyadenosine therapy in patients with T-cell lymphoproliferative disordersS O'Brien, R Kurzrock, M Duvic, et al.
Leukemia|March 1, 1988
Multiple agent chemotherapy (POACH) in previously treated and untreated patients with chronic lymphocytic leukemiaM J Keating, M Scouros, S Murphy, et al.
The Journal of Clinical Investigation|July 1, 1985
Pretreatment of cytokinetics in acute myelogenous leukemia. Age-related prognostic implicationsH M Kantarjian, B Barlogie, M J Keating, et al.
Leukemia|September 1, 1995
A 3-day schedule of fludarabine in previously treated chronic lymphocytic leukemiaL E Robertson, S O'Brien, H Kantarjian, et al.
American Journal of Clinical Pathology|March 1, 1994
Detection of subgroups of chronic B-cell leukemias by FMC7 monoclonal antibodyY O Huh, W C Pugh, H M Kantarjian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Fludarabine--present status and future developments in chronic lymphocytic leukemia and lymphomaM J Keating, P McLaughlin, W Plunkett, et al.
Pageof 44